MIB2 and dermatitis: The distinct skin phenotype, including exacerbated dermatitis and excessive epidermal hyperplasia observed in the absence of MIB2 in the context of the Sharpin cpd mutation is noteworthy, particularly given that no exacerbation of other cpdm-driven phenotype was observed.